Goldman Sachs
RXST icon

Goldman Sachs’s RxSight RXST Stock Holding History

Goldman Sachs’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.05M Sell
495,704
-69,486
-12% -$577K ﹤0.01% 4154
2025
Q4 		$5.89M Buy
565,190
+191,643
+51% +$1.92M ﹤0.01% 3599
2025
Q3 		$3.36M Buy
373,547
+121,300
+48% +$1.06M ﹤0.01% 4018
2025
Q2 		$3.28M Sell
252,247
-58,164
-19% -$874K ﹤0.01% 3807
2025
Q1 		$7.84M Buy
310,411
+113,767
+58% +$3.38M ﹤0.01% 2921
2024
Q4 		$6.76M Buy
196,644
+64,104
+48% +$2.89M ﹤0.01% 3156
2024
Q3 		$6.55M Buy
132,540
+38,389
+41% +$1.97M ﹤0.01% 3111
2024
Q2 		$5.67M Sell
94,151
-22,839
-20% -$1.31M ﹤0.01% 3037
2024
Q1 		$6.03M Buy
116,990
+20,846
+22% +$1.02M ﹤0.01% 2921
2023
Q4 		$3.88M Buy
96,144
+32,068
+50% +$941K ﹤0.01% 3376
2023
Q3 		$1.79M Sell
64,076
-36,603
-36% -$1.09M ﹤0.01% 3849
2023
Q2 		$2.9M Buy
100,679
+23,710
+31% +$527K ﹤0.01% 3588
2023
Q1 		$1.28M Buy
+76,969
New +$1.09M ﹤0.01% 4202

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Goldman Sachs's RXST Position: Q1 2026 in Review

Goldman Sachs reduced its RxSight (RXST) stake by 12% in Q1 2026, selling an estimated $577K and leaving 495,704 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #4154.

Goldman Sachs first reported a position in RXST in Q1 2023 and has held it in 13 quarters since. The position peaked at $7.84M in Q1 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Goldman Sachs held 495,704 shares of RxSight worth $3.05M as of Q1 2026.
  • Goldman Sachs sold 69,486 RxSight shares in Q1 2026, an estimated $577K.
  • RxSight made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4154 holding.
  • Goldman Sachs first reported a position in RxSight in Q1 2023 and has held it in 13 quarters since.
  • Goldman Sachs's RxSight position peaked at $7.84M in Q1 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.